Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Intravenous Magnesium Sulfate in Acute Stroke


Phase 3 Results

Eligibility Criteria

Inclusion Criteria

Patients presenting within 12 hours of clinically diagnosed middle cerebral artery stroke, at least 18 years of age.

Exclusion Criteria

Pregnancy, known renal failure, or preexisting functional impairment that would impair assessment.